PRMT1 and nonpapillary renal cell carcinoma: PRMT1 has already been studied in ccRCCs, results showing higher expression in low grade and low stage of ccRCC and loss of PRMT1 in high grade and high stage ccRCC, showcasing its duality (Filipović et al., 2019).